loSIIN
(Plasmid
#185663)
-
PurposeshApc-expressing lentiviruses with varius levels of expression of SIINFEKL
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 185663 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLenti Trono
-
Vector typeLentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert namemScarlet
-
SpeciesSynthetic
- Promoter Ef1a
Cloning Information for Gene/Insert 1
- Cloning method Gibson Cloning
- 5′ sequencing primer N/A
- 3′ sequencing primer N/A (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namemiR-30a
- Promoter Ef1a
Cloning Information for Gene/Insert 2
- Cloning method Gibson Cloning
- 5′ sequencing primer N/A
- 3′ sequencing primer N/A (Common Sequencing Primers)
Gene/Insert 3
-
Gene/Insert nameshApc
- Promoter Ef1a
Cloning Information for Gene/Insert 3
- Cloning method Gibson Cloning
- 5′ sequencing primer N/A
- 3′ sequencing primer N/A (Common Sequencing Primers)
Gene/Insert 4
-
Gene/Insert nameGFP
-
SpeciesSynthetic
- Promoter Ef1a
Cloning Information for Gene/Insert 4
- Cloning method Gibson Cloning
- 5′ sequencing primer N/A
- 3′ sequencing primer N/A (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byLuke Dow mir30 shAPC.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
loSIIN was a gift from Tyler Jacks (Addgene plasmid # 185663 ; http://n2t.net/addgene:185663 ; RRID:Addgene_185663) -
For your References section:
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer. Westcott PMK, Sacks NJ, Schenkel JM, Ely ZA, Smith O, Hauck H, Jaeger AM, Zhang D, Backlund CM, Beytagh MC, Patten JJ, Elbashir R, Eng G, Irvine DJ, Yilmaz OH, Jacks T. Nat Cancer. 2021 Oct;2(10):1071-1085. doi: 10.1038/s43018-021-00247-z. Epub 2021 Sep 30. 10.1038/s43018-021-00247-z PubMed 34738089